A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir–Torre variant of Lynch syndrome | Zendy

Maegan E. Roberts | Zendy; Douglas L. RiegertJohnson | Zendy; Brittany C. Thomas | Zendy; Kandelaria M. Rumilla | Zendy; Colleen S. Thomas | Zendy; Michael G. Heckman | Zendy; Jennifer U. Purcell | Zendy; Nancy Hanson | Zendy; Kathleen A. Leppig | Zendy; Justin Lim | Zendy; Mark A. Cappel | Zendy

Open Access

A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir–Torre variant of Lynch syndrome

Author(s) -

Maegan E. Roberts,

Douglas L. RiegertJohnson,

Brittany C. Thomas,

Kandelaria M. Rumilla,

Colleen S. Thomas,

Michael G. Heckman,

Jennifer U. Purcell,

Nancy Hanson,

Kathleen A. Leppig,

Justin Lim,

Mark A. Cappel

Publication year - 2014

Publication title -

genetics in medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.509

H-Index - 128

eISSN - 1530-0366

pISSN - 1098-3600

DOI - 10.1038/gim.2014.19

Subject(s) - lynch syndrome , sebaceous carcinoma , medicine , colorectal cancer , family history , cancer , oncology , microsatellite instability , sebaceous gland , carcinoma , dna mismatch repair , biology , gene , genetics , allele , microsatellite

The Muir-Torre syndrome variant of Lynch syndrome is characterized by the presence of sebaceous neoplasms (adenoma, epithelioma/sebaceoma, carcinoma) and Lynch syndrome-associated cancers (colon, endometrial, and others). Several clinical scoring systems have been developed to identify patients with colon cancer at high risk of Lynch syndrome. However, no such system has been described for patients presenting with sebaceous neoplasms.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research